Cabergoline may provide the following benefits when used as prescribed:
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Cabergoline is a long-acting dopamine receptor agonist used to treat conditions associated with abnormally high levels of the hormone prolactin in the blood. It is primarily used for hyperprolactinemic disorders, including prolactin-secreting pituitary tumors (prolactinomas).
By reducing prolactin secretion, cabergoline can help restore hormonal balance and improve symptoms such as irregular menstrual periods, infertility related to elevated prolactin, reduced libido, and unwanted breast milk production.
Cabergoline may also be prescribed to suppress breast milk production when medically indicated.
Cabergoline is used for the treatment of:
Cabergoline stimulates dopamine D2 receptors in the pituitary gland. Dopamine naturally suppresses prolactin secretion, and cabergoline mimics this effect.
As a result, cabergoline reduces the release of prolactin from the pituitary gland and helps normalize elevated prolactin levels.
Cabergoline may cause a sudden decrease in blood pressure, particularly when treatment is started or when the dose is increased. Monitor blood pressure as advised by your doctor and rise slowly from sitting or lying positions.
Cabergoline may cause dizziness, drowsiness, or sudden episodes of sleepiness in some patients. Avoid driving, operating machinery, or performing hazardous activities until you know how the medicine affects you.
Dopamine agonists, including cabergoline, have occasionally been associated with impulse-control problems. These may include unusually strong or uncontrollable urges such as gambling, excessive spending, binge eating, or increased sexual activity. Inform your doctor promptly if you or your family notice significant behavioural changes.
Regular medical follow-up may be required to monitor prolactin levels and, particularly during long-term treatment, assess cardiovascular, pulmonary, or other relevant health parameters.
Cabergoline may interact with certain medicines and affect their action or increase the risk of adverse effects.
Taking cabergoline with antihypertensive medicines may increase the risk of excessive blood-pressure reduction, dizziness, lightheadedness, or fainting.
Medicines that block dopamine receptors may reduce the effectiveness of cabergoline. Examples include:
Certain macrolide antibiotics, such as erythromycin and clarithromycin, may increase exposure to cabergoline and potentially increase adverse effects. Inform your doctor if you are prescribed these medicines.
Concurrent use with other ergot alkaloids, such as ergotamine or dihydroergotamine, should only be undertaken under medical supervision.
Always inform your doctor about all prescription medicines, over-the-counter medicines, and supplements you are taking.
If you are pregnant, planning to become pregnant, or think you may be pregnant, consult your doctor before taking cabergoline.
If pregnancy occurs during treatment, contact your doctor promptly. Whether treatment should be continued or discontinued depends on the reason for treatment and the individual clinical situation.
Women receiving cabergoline for hyperprolactinemia may require appropriate pregnancy monitoring and medical follow-up.
Cabergoline suppresses prolactin secretion and can reduce or prevent breast milk production. Therefore, it should not be used by women who intend to establish or continue breastfeeding unless specifically prescribed by a doctor for an appropriate medical reason.
Alcohol may worsen dizziness, drowsiness, or lightheadedness associated with cabergoline. Avoid or limit alcohol during treatment and follow your doctor's advice.
Cabergoline should be used cautiously in patients with liver disease. Patients with hepatic impairment may require individualized dosing and closer medical monitoring.
Inform your doctor if you have kidney disease before starting cabergoline. Your doctor will determine whether any additional monitoring or dose adjustment is necessary based on your condition.
Cabergoline is not routinely used in children unless specifically prescribed by a specialist for an appropriate medical condition. Pediatric use should be determined by a qualified healthcare professional.
Some patients may experience:
These effects may be more noticeable when treatment is first started or after a dose increase.
Seek medical attention if you experience:
Long-term treatment may require monitoring for rare fibrotic complications and heart-valve abnormalities.
Hyperprolactinemia is a condition in which the level of prolactin in the blood is higher than normal.
Depending on the cause, elevated prolactin may lead to:
In men, elevated prolactin may contribute to reduced libido, erectile or reproductive problems, and low testosterone.
Regular monitoring may include blood pressure and serum prolactin levels. Depending on the duration of treatment, dose, and individual risk factors, your doctor may also recommend evaluation of heart or lung function.
Tell your doctor if you have a history of:
Cabergoline is not considered habit-forming.
Store in a cool, dry place away from direct sunlight and excessive heat. Keep out of reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.